The sales volume of the three major American enterprises of pharmaceutical wholesales accounts for more than 90% of the domestic market shares. The sales volume of the five major Japanese pharmaceutical wholesale enterprises accounts for 80% of the domestic market shares and the three major European pharmaceutical wholesale enterprises account for 65% of the region's shares. Meanwhile£¬the three major wholesalers in China, China National Pharmaceutical Group, Shanghai Pharmaceutical Co., Ltd and Jointown Group Co., Ltd, only accounted for 23% of the domestic market shares in 2005 even after nearly two years of rapid development.

According to the industrial statistics, currently there are 16.5 thousand pharmaceutical wholesale enterprises nationwide. Only 10 of them have a sales volume exceeding 1 billion Yuan. Only 3 to 6 of them each have a sales volume of more than 5 billion. There are nearly 140 thousand retail businesses and the annual turnover of the largest chain store is only 500 million Yuan. There are a total of 120 thousand retail pharmaceutical stores and more than 6.3 thousand pharmaceutical manufacturing enterprises. China National Pharmaceutical Group, Shanghai Pharmaceutical Co., Ltd and Jointown Group Co., Ltd, which have the largest sales volume, only account for 3% to 5% or so of the pharmaceutical market total sales volume respectively. However America's top 3 pharmaceutical retailers' sales volume has accounted for more than 95% of the entire pharmaceutical markets', in which McKesson ranked first and Cardinal Health ranked second, their market share being over 30% each. Under this circumstance, a new round of mergers and restructuring waves can easily happen if large amounts of external investment enter. Some enterprises who can't meet the competition will be eliminated while some large enterprises will gradually achieve regional monopoly and earn high profits. Pharmaceutical logistics industry develops from a general and traditional one to a large-scale and modern one.

In order to raise the level of Chinese pharmaceutical distribution industry, in the Ten Five-Year Plan for the pharmaceutical industry, the state proposed to bring up 5-10 specially big pharmaceutical distribution enterprise groups which target domestic and foreign markets, operate diversely and have a sales volume of more than 5 billion Yuan each; and to establish 40 or so big pharmaceutical distribution enterprise groups which target domestic market or domestic regional markets, with a sales volume of more than 2 billion Yuan each. Sales volume of these enterprises reaches over 70% of total pharmaceutical industry sales. The state also proposed to establish 10 pharmaceutical retail chain enterprises famous at home and abroad, which have more than 1,000 branch stores each and to establish a batch of regional pharmaceutical retail chain enterprises, which have 100 or so branch stores each; to achieve a strong alliance among manufacturers, wholesalers and retailers or among wholesalers, reduce logistics costs and enhance logistics efficiency and service levels, through integrated development.

2. Pharmaceutical market analysis and forecast, 2005-2006
2.1 International market analysis and forecast
2.1.1 Global pharmaceutical industry situation analysis in 2005
2.1.2 Dynamic analysis of the main regional markets in 2005 
2.1.3Global pharmacy industry forecast analysis in 2006
2.2 Domestic market analysis and forecast
2.1.1 Review and analysis of the pharmaceutical industry in 2005
2.1.2 Pharmaceutical sales channels and market dynamics analysis, 2005-2006
2.1.3 Trend analysis of medicine used in hospitals in China, 2001-2005
2.1.4 Chinese pharmaceutical market analysis and forecast in 2006

3. Pharmaceutical logistics condition analysis
3.1 International pharmaceutical logistics condition analysis
3.1.1 Nowadays' logistics industry development trends
3.1.2 Foreign-owned companies' first appearance in domestic pharmaceutical circulation
3.2Domestic pharmaceutical logistics condition analysis
3.2.1 China's pharmaceutical logistics present condition analysis in 2006
3.2.2 China's logistics industry development pattern analysis and pharmaceutical logistics industry in 2006
3.2.3 Pharmaceutical logistics market size analysis in2006
3.3Pharmaceutical marketing channels investment and logistics information platform model discussion, 2006-2007
3.3.1 Changes of pharmaceutical logistics incubated channels
3.3.2 China's several typical pharmaceutical logistics information platform models discussion

4 Retail dynamics analysis of pharmaceutical logistics industry chain 
4.1 Analysis of present condition of China's pharmaceuticals retail enterprises in 2005
4.2 Pharmaceutical retail market analysis in 2005
4.2.1 Influences on retail market brought by pharmaceutical price reduction 
4.2.2 New pharmaceutical retail models recommendation
4.2.3 Parity stimulates pharmaceutical logistics
4.3 Pharmaceutical circulation and channel operation tactics
4.3.1 Common pharmaceutical market exploitation and channel creation tactics
4.3.2 Pharceutical direct marketing study
4.4 Retail market development trend analysis, 2006-2007 
4.4.1 Cross provinces chain discussion of pharmaceutical retail industry
4.4.2 Futual pharmacy development direction 

5 Introduction and front dynamics of major pharmaceutical logistic enterprises
5.1 Division and introduction of major enterprises in 2005
5.1.1 Major logistic enterprises division
5.1.2 Major pharmaceutical logistic enterprises introduction
5.2 Front dynamics of present pharmaceutical logistics
5.2.1 Large pharmaceutical logistics establishment in Tianjin pharmaceutical city
5.2.2 Establishment of first pharmaceutical logistic delivery centre in Beijing
5.2.3 Pharmaceutical division sale giants' competition for large pharmacy establishment in Shanghai
5.2.4 Mayinglong Pharmaceutical Industry Investment Logistics
5.2.5 Completion of northeast pharmaceutical logistics centre project 
5.2.6 Gaosheng's will of investment in Neptunus pharmaceutical logistics
5.2.7 Luoyang invested 800 million to establish the biggest pharmaceutical logistics centre in Central Plains
5.3 Supplies and needs analysis of pharmaceutical logistics market
5.3.1 Supply and need situation analysis of China's logistics industry 
5.3.2 Supply chain management's connection with pharmaceutical enterprises profit chain
5.3.3 Modern pharmaceutical logistics establishment should combine with market need
5.3.4 Pharmaceutical and logistics enterprises operation tactics discussion in 2006
5.3.5 Pharmaceutical enterprises logistics integration and benefit maximum analysis

6 Successful pharmaceutical logistics cases analysis
6.1 Sanjiu Medical and Pharmaceutical Co., Ltd logistics operation model
6.2 Yunnan Shuanghe Pharmaceutical's reasonable store system reconstructive
6.3 Shandong Lukang pharmaceutical group improves logistics management and competition ability

7 Pharmaceutical logistics investment and risk prevention analysis, 2006-2007
7.1 Pharmaceutical industry's getting into marginal profit period stimulates pharmaceutical logistics development 
7.2 Industry policies risk analysis
7.2.1 Policy system's influences on investment in China's logistics industry development 
7.2.2 Analysis of pharmaceutical logistics system innovation's influences on investment risk 
7.3 China's pharmaceutical logistics investment risk analysis
7.3.1 Pharmaceutical logistics market investment analysis
7.3.2 Several attentive investment points 
7.3.3 Risk prevention tactics and measures
7.4 Analysis and suggestions for investment in future pharmaceutical logistics field investment 

8 Pharmaceutical logistics development trend analysis
8.1 China's pharmaceutical logistics industry development trend analysis
8.2 China's pharmaceutical logistics industry's future trend forecast